---
{"dg-publish":true,"permalink":"/USMLE/MSK/Idiopathic inflammatory myopathies/"}
---

# Definition
- Dermatomyositis (DM): an inflammatory myopathy characterized by <span style="background:rgba(240, 200, 0, 0.2)">progressive symmetrical proximal muscle weakness and distinctive skin findings</span>
- Polymyositis (PM): an inflammatory myopathy <span style="background:rgba(240, 200, 0, 0.2)">affecting the proximal skeletal muscles</span>, with evidence of elevated CK and myositis on EMG and biopsy in the absence of any of the characteristic findings of the other IIM (a rare diagnosis of exclusion)

---
# Epidemiology


---
# Etiology
- Polymyositis (PM): <span style="background:rgba(240, 200, 0, 0.2)">cell-mediated cytotoxicity</span> against unidentified skeletal muscle antigens, chiefly affecting the endomysium
- Dermatomyositis (DM): idiopathic or paraneoplastic <span style="background:rgba(240, 200, 0, 0.2)">antibody-mediated </span>vasculopathy, <span style="background:rgba(240, 200, 0, 0.2)">associated with malignancies ([[USMLE/Blood/Non-Hodgkin lymphomas\|non-Hodgkin lymphoma]]; lung, stomach, colorectal, or [[USMLE/Reproductive/Ovarian cancer\|ovarian cancer]] )</span>
	- may occur alone or as a [[USMLE/Respiratory/Paraneoplastic syndromes\|paraneoplastic syndrome]] of an underlying malignancy, most commonly due to underlying adenocarcinoma (eg, ovary, lung, pancreas).

---
# Pathophysiology


---
# Clinical features
![Pasted image 20230923164647.png](/img/user/appendix/Pasted%20image%2020230923164647.png)
## Muscle weakness
- Limb weakness
	- <span style="background:rgba(240, 200, 0, 0.2)">Symmetrical proximal muscle weakness and atrophy</span>
	- Commonly affects <span style="background:rgba(240, 200, 0, 0.2)">pelvic and shoulder girdle muscles</span>, leading to difficulties combing hair, standing up from a sitting position, and climbing stairs
- Axial muscle weakness
	- <span style="background:rgba(240, 200, 0, 0.2)">Oropharyngeal muscle weakness leading to dysphagia</span>
## Cutaneous features 
Cutaneous features are characteristic of dermatomyositis but may be found in other subtypes.
- Symmetric erythematous rash on the: 
	- <span style="background:rgba(240, 200, 0, 0.2)">Extensor surfaces of the hand joints</span>, elbows, and knees (Gottron sign); scaly papules may form (<span style="background:rgba(240, 200, 0, 0.2)">Gottron papules</span>)![L10726.png](/img/user/appendix/L10726.png)
	- <span style="background:rgba(240, 200, 0, 0.2)">Upper eyelids (heliotrope rash)</span>; often associated with periorbital edema![L10630.png](/img/user/appendix/L10630.png)
	- Mid-face 
	- Upper back, posterior neck, and shoulders (shawl sign)
	- Upper chest and anterior neck (V sign)
- <span style="background:rgba(240, 200, 0, 0.2)">Mechanic's hands</span>: thickened and cracked skin on the sides of the fingers and palms (horizontal fissures may appear darkened or dirty, hence the name)![Pasted image 20250418110140.png](/img/user/appendix/Pasted%20image%2020250418110140.png)



>[!tip] 
>The clinical features of PM is similar to DM except no cutaneous features.

---
# Diagnostics
- ↑ CK
- Antinuclear antibodies (ANAs)
- Myositis-specific antibodies
	- <span style="background:rgba(240, 200, 0, 0.2)">Anti-Jo-1 antibodies</span> (anti–histidyl-<span style="background:rgba(240, 200, 0, 0.2)">tRNA</span> synthetase)![Pasted image 20240116151535.png](/img/user/appendix/Pasted%20image%2020240116151535.png)
- Muscle biopsy: Gold standard for diagnosis of IIM
	- Typical findings
		- <span style="background:rgba(240, 200, 0, 0.2)">Muscle fiber damage</span>
			- <span style="background:rgba(240, 200, 0, 0.2)">Necrosis</span>, degeneration, and regeneration
		- Inflammatory cellular infiltrates
			- <span style="background:rgba(240, 200, 0, 0.2)">DM</span>:<span style="background:rgba(240, 200, 0, 0.2)"> antibody-mediated</span> inflammatory infiltrates that predominantly involve <span style="background:rgba(240, 200, 0, 0.2)">CD4+ T cells</span>, plasmacytoid dendritic cells, and B lymphocytes in the <span style="background:rgba(240, 200, 0, 0.2)">perimysium</span> (the connective tissue surrounding the fascicle); can lead to <span style="background:rgba(240, 200, 0, 0.2)">perifascicular atrophy  </span>
			- IBM and <span style="background:rgba(240, 200, 0, 0.2)">PM</span>: <span style="background:rgba(240, 200, 0, 0.2)">cell-mediated</span> inflammatory infiltrates that predominantly involve cytotoxic <span style="background:rgba(240, 200, 0, 0.2)">CD8+ T cells</span> in the <span style="background:rgba(240, 200, 0, 0.2)">endomysium</span> (the connective tissue surrounding each muscle fiber), <span style="background:rgba(240, 200, 0, 0.2)">patchy necrosis</span>

# Differential diagnostics
---
## Dermatomyositis vs. Systemic Sclerosis

| **Feature**       | **Dermatomyositis (DM)**                                                                                     | **Systemic Sclerosis (SSc)**                                                                                             |
| ----------------- | ------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------ |
| **Primary Issue** | Muscle & skin inflammation (capillary damage)                                                                | Widespread **fibrosis** & vasculopathy                                                                                   |
| **Key Skin**      | **Gottron's papules**, **Heliotrope rash**, Shawl/V-sign, Mechanic's hands                                   | **Skin thickening/tightening (scleroderma)**, Sclerodactyly, Telangiectasias, Calcinosis, Raynaud's (often first)        |
| **Muscle**        | <span style="background:rgba(240, 200, 0, 0.2)">**Symmetric proximal weakness** (prominent), myalgias</span> | <span style="background:rgba(240, 200, 0, 0.2)">Often mild or late; arthralgias/tendon rubs more common</span>           |
| **Key Organ**     | **Interstitial Lung Disease (ILD)**, dysphagia (skeletal muscle)                                             | **ILD**, **Pulmonary Arterial Hypertension (PAH)**, Esophageal dysmotility (smooth muscle), **Scleroderma Renal Crisis** |
| **Antibodies**    | **Anti-Jo-1** (ILD), **Anti-Mi-2** (classic skin), Anti-MDA5 (amyopathic, severe ILD), Anti-TIF1-γ (cancer)  | **Anti-Scl-70** (diffuse, ILD), **Anti-centromere** (limited/CREST, PAH), Anti-RNA Pol III (renal crisis)                |
| **Malignancy**    | **High risk** (ovary, lung, etc.)                                                                            | Slight increase (e.g., lung with ILD)                                                                                    |
| **Tx Pearl**      | Corticosteroids, immunosuppressants; **Cancer screening crucial**                                            | Organ-based; **ACE Inhibitors for Renal Crisis (VITAL!)**                                                                |
| **Subtype/Note**  | Amyopathic DM (skin, no weakness)                                                                            | Limited (CREST) vs. Diffuse variants                                                                                     |
# Treatment


---
